Tilray (NASDAQ:TLRY – Get Free Report) announced its quarterly earnings results on Friday. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.07), Zacks reports. Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. The company had revenue of $210.90 million during the quarter, compared to the consensus estimate of $216.34 million. The company’s revenue was up 8.7% compared to the same quarter last year. Tilray updated its FY 2025 guidance to EPS.
Tilray Stock Down 10.2 %
Shares of TLRY stock opened at $1.23 on Friday. The company has a current ratio of 2.47, a quick ratio of 1.57 and a debt-to-equity ratio of 0.08. Tilray has a 12 month low of $1.14 and a 12 month high of $2.97. The stock has a market cap of $1.11 billion, a P/E ratio of -4.56 and a beta of 2.08. The company has a 50 day simple moving average of $1.36 and a two-hundred day simple moving average of $1.62.
Wall Street Analysts Forecast Growth
Separately, Roth Mkm lowered their price target on Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a report on Friday, October 11th.
Insider Transactions at Tilray
In related news, CFO Carl A. Merton acquired 26,000 shares of the firm’s stock in a transaction dated Friday, November 15th. The shares were purchased at an average price of $1.36 per share, with a total value of $35,360.00. Following the completion of the purchase, the chief financial officer now directly owns 26,000 shares of the company’s stock, valued at $35,360. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.87% of the company’s stock.
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.
See Also
- Five stocks we like better than Tilray
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
- How to Use the MarketBeat Dividend Calculator
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- What Is WallStreetBets and What Stocks Are They Targeting?
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.
